How would you measure the success of Omada's digital diabetes prevention program?

Introduction

Measuring the success of Omada's digital diabetes prevention program requires a comprehensive approach that considers multiple stakeholders and various aspects of the product. To effectively evaluate this digital health intervention, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Omada's digital diabetes prevention program is a mobile and web-based platform designed to help individuals at risk of developing type 2 diabetes make sustainable lifestyle changes. The program combines personalized coaching, peer support, and digital tools to guide users through a curriculum focused on nutrition, physical activity, and behavior change.

Key stakeholders include:

1. Users (individuals at risk of diabetes)
2. Healthcare providers
3. Employers or health plans (who often sponsor the program)
4. Omada Health (the company)

User flow:

1. Onboarding: Users complete a risk assessment and receive a connected scale and activity tracker.
2. Weekly lessons: Participants engage with educational content on nutrition, exercise, and behavior change.
3. Tracking: Users log meals, activity, and weight using the app or connected devices.
4. Coaching: Participants receive personalized feedback and support from a health coach.
5. Community: Users interact with peers in small groups for motivation and accountability.

This program aligns with Omada's broader strategy of leveraging technology to deliver evidence-based behavioral interventions for chronic disease prevention and management. Compared to competitors like Livongo or Noom, Omada's program emphasizes personalized coaching and a curriculum based on the CDC's Diabetes Prevention Program.

The product is in the growth stage of its lifecycle, with a focus on scaling user acquisition and demonstrating long-term health outcomes to drive adoption by more health plans and employers.